Insider buying
~$357K37K sh @ $9.60
Traded Dec 3, 2024 · filed 2 days later
A Benitec Biopharma director paid $357K out of pocket for Benitec Biopharma shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 19, 2024 · Filed Nov 21, 2024
A Benitec Biopharma director paid $15K out of pocket for Benitec Biopharma shares. It was the first purchase in over a year.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$15,276
Shares × reported transaction price
<$25K
+0.2%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
None in 13 months of history
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
5 days after results of Nov 14, 2024, 87 days before results of Feb 14, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.8% | +1.2% | −5.0% |
| 30 days | +7.2% | −0.1% | +7.3% |
| 90 days | +10.3% | +2.5% | +7.8% |
| 180 days | +30.3% | −2.1% | +32.4% |
| 365 days | +24.6% | +12.3% | +12.3% |
Past results only. Not a forecast.
Insider buying
Traded Dec 3, 2024 · filed 2 days later
A Benitec Biopharma director paid $357K out of pocket for Benitec Biopharma shares.
Insider buying
Traded Dec 3, 2024 · filed 2 days later
A Benitec Biopharma director paid $46K out of pocket for Benitec Biopharma shares.
Insider buying
Traded Nov 20, 2024 · filed 1 day later
A Benitec Biopharma director paid $31K out of pocket for Benitec Biopharma shares.
SUVRETTA CAPITAL MANAGEMENT, LLC, Director's past purchases, 90 days after disclosure: 5 buys, median +7.8 pts vs S&P 500, beat it 3 of 5 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.